• By ICR Secretariat
• Posted Thursday, August 31, 2023

NICE gives green light for MSD's Keytruda

https://www.pharmatimes.com/news/nice_gives_green_light_for_msds_keytruda_1496559

The decision is the first verdict based on data from a wider immunotherapy ‘basket’ study

MSD has revealed that the National Institute for Health and Care Excellence (NICE) has recommended the use of Keytruda.